{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:24:18Z","timestamp":1783488258122,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaut.2021.102666","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:13:54Z","timestamp":1623766434000},"page":"102666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine \/collagen content in a long-term Graves\u2019 disease mouse model"],"prefix":"10.1016","volume":"122","author":[{"given":"Tanja","family":"Diana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"W\u00fcster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fa\u00dfbender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Holthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kanitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaut.2021.102666_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/en.2014-1813","article-title":"Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy","volume":"156","author":"Holthoff","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2021.102666_bib2","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.2741\/4688","article-title":"Antigen-specific therapy of Graves disease and orbitopathy by induction of tolerance","volume":"23","author":"Ungerer","year":"2018","journal-title":"Front. Biosci."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2021.102666_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000508790","article-title":"A novel long-term graves' disease animal model confirmed by functional thyrotropin receptor antibodies","volume":"9","author":"Diana","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jaut.2021.102666_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fendo.2017.00028","article-title":"TSH receptor antibody functionality and nomenclature","volume":"8","author":"Kahaly","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"4S Suppl 1","key":"10.1016\/j.jaut.2021.102666_bib5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","article-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications","volume":"34","author":"Diana","year":"2018","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"issue":"12","key":"10.1016\/j.jaut.2021.102666_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/a-0723-9023","article-title":"Thyrotropin receptor blocking antibodies","volume":"50","author":"Diana","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.jaut.2021.102666_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4158\/EP-2019-0363","article-title":"Tsh receptor antibodies: relevance & utility","volume":"26","author":"Kahaly","year":"2020","journal-title":"Endocr. Pract."},{"issue":"5","key":"10.1016\/j.jaut.2021.102666_bib8","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/jc.2013-4026","article-title":"Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study","volume":"99","author":"Diana","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jaut.2021.102666_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s40618-016-0478-9","article-title":"Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies","volume":"39","author":"Diana","year":"2016","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"10.1016\/j.jaut.2021.102666_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000478522","article-title":"Performance and specificity of 6 immunoassays for TSH receptor antibodies: a multicenter study","volume":"6","author":"Diana","year":"2017","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.jaut.2021.102666_bib11","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2018-00509","article-title":"Stimulatory TSH-receptor antibodies and oxidative stress in graves disease","volume":"103","author":"Diana","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jaut.2021.102666_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/a-0914-0535","article-title":"Comparison of a bridge immunoassay with two bioassays for thyrotropin receptor antibody detection and differentiation","volume":"51","author":"Allelein","year":"2019","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.jaut.2021.102666_bib13","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jaut.2021.102666_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.jaut.2021.102666_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40618-019-01116-4","article-title":"Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy","volume":"43","author":"Hai","year":"2020","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.jaut.2021.102666_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-020-01380-9","article-title":"Thyrotropin receptor antibodies and Graves' orbitopathy","volume":"44","author":"Diana","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"10.1016\/j.jaut.2021.102666_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40618-019-01161-z","article-title":"Systemic safety analysis of mycophenolate in Graves' orbitopathy","volume":"43","author":"Lee","year":"2020","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.jaut.2021.102666_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12016-016-8562-7","article-title":"Review of mouse models of graves' disease and orbitopathy-novel treatment by induction of tolerance","volume":"52","author":"Ungerer","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2021.102666_bib19","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/en.2016-1845","article-title":"Cyclic peptides for effective treatment in a long-term model of graves disease and orbitopathy in female mice","volume":"158","author":"Holthoff","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jaut.2021.102666_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/thy.2018.0326","article-title":"Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of graves' disease and orbitopathy","volume":"29","author":"Fassbender","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.jaut.2021.102666_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2249.2010.04266.x","article-title":"Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins","volume":"162","author":"Lytton","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102666_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1309\/AJCPZUT7CNUEU7OP","article-title":"Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins","volume":"139","author":"Leschik","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102666_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/thy.2014.0346","article-title":"Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies","volume":"25","author":"Diana","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.jaut.2021.102666_bib24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cei.12129","article-title":"A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity","volume":"173","author":"Li","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102666_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1089\/thy.2015.0447","article-title":"Analytical performance and validation of a bioassay for thyroid-blocking antibodies","volume":"26","author":"Diana","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.jaut.2021.102666_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1440-1746.2004.03183.x","article-title":"Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software","volume":"19","author":"Dahab","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jaut.2021.102666_bib27","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1210\/en.2009-0181","article-title":"Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies","volume":"150","author":"Misharin","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jaut.2021.102666_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clim.2007.11.007","article-title":"Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor","volume":"127","author":"Arima","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102666_bib29","doi-asserted-by":"crossref","unstructured":"M. Zhang, X. Ding, L. P. Wu, M. Q. He, Z. Y. Chen, B. Y. Shi et al. A promising mouse model of graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit. Thyroid (2021 Jan 5. doi: 10.1089\/thy.2020.0088. Epub ahead of print. PMID: 33076782.).","DOI":"10.1089\/thy.2020.0088"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2021.102666_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000508789","article-title":"Novel approaches for immunosuppression in graves' hyperthyroidism and associated orbitopathy","volume":"9","author":"Lee","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2021.102666_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000511538","article-title":"Targeting TSH and IGF-1 receptors to treat thyroid eye disease","volume":"9","author":"Neumann","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jaut.2021.102666_bib32","doi-asserted-by":"crossref","unstructured":"H. Degen, I. Gavvovidis, T. Blankenstein, K. Uhland, M. Ungerer. Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in graves' disease patient blood. Thyroid (2021 Feb 8. doi: 10.1089\/thy.2020.0338. PMID: 33208049).","DOI":"10.1089\/thy.2020.0338"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:10Z","timestamp":1760257690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"alternative-id":["S0896841121000743"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102666","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine \/collagen content in a long-term Graves\u2019 disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102666"}}